Last reviewed · How we verify

Oxymetazoline hydrochloride Cream, 1%

Sun Pharmaceutical Industries, Inc. · Phase 1 active Small molecule

Oxymetazoline hydrochloride Cream, 1% is a Small molecule drug developed by Sun Pharmaceutical Industries, Inc.. It is currently in Phase 1 development. Also known as: Oxymetazoline.

At a glance

Generic nameOxymetazoline hydrochloride Cream, 1%
Also known asOxymetazoline
SponsorSun Pharmaceutical Industries, Inc.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Oxymetazoline hydrochloride Cream, 1%

What is Oxymetazoline hydrochloride Cream, 1%?

Oxymetazoline hydrochloride Cream, 1% is a Small molecule drug developed by Sun Pharmaceutical Industries, Inc..

Who makes Oxymetazoline hydrochloride Cream, 1%?

Oxymetazoline hydrochloride Cream, 1% is developed by Sun Pharmaceutical Industries, Inc. (see full Sun Pharmaceutical Industries, Inc. pipeline at /company/sun-pharmaceutical-industries-inc).

Is Oxymetazoline hydrochloride Cream, 1% also known as anything else?

Oxymetazoline hydrochloride Cream, 1% is also known as Oxymetazoline.

What development phase is Oxymetazoline hydrochloride Cream, 1% in?

Oxymetazoline hydrochloride Cream, 1% is in Phase 1.

Related